Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease (SAPHIR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02389413
Recruitment Status : Completed
First Posted : March 17, 2015
Last Update Posted : June 1, 2017
Julius Clinical, The Netherlands
VU University Medical Center
Information provided by (Responsible Party):
Vivoryon Therapeutics N.V.